NCT03546231

Brief Summary

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 13, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

7.3 years

First QC Date

April 13, 2018

Last Update Submit

February 9, 2023

Conditions

Tricuspid Valve Disease

Keywords

Tricuspid regurgitationtricuspid valvesurgeryoutcomeprognosismortalityright ventricleasymptomatic

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    It corresponds to the delay between the diagnostic and the date of death.

    5 Years

Eligibility Criteria

Age18 Months+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with moderate or severe tricuspid regurgitation.

You may qualify if:

  • Age \>18 ans

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

RECRUITING

MeSH Terms

Conditions

Tricuspid Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Study Officials

  • Christophe TRIBOUILLOY, Pr

    CHU AMIENS-PICARDIE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christophe TRIBOUILLOY, Pr

CONTACT

03 22 45 58 85Tribouilloy.Christophe@chu-amiens.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2018

First Posted

June 6, 2018

Study Start

March 2, 2018

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

February 10, 2023

Record last verified: 2023-02

Locations

FR(1)